- Home
- UONEK vs COEP Comparison
UONEK vs COEP Comparison
Compare UONEK & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- COEP
- Stock Information
- Founded
- UONEK 1980
- COEP 2017
- Country
- UONEK United States
- COEP United States
- Employees
- UONEK N/A
- COEP N/A
- Industry
- UONEK Broadcasting
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UONEK Consumer Discretionary
- COEP Health Care
- Exchange
- UONEK Nasdaq
- COEP Nasdaq
- Market Cap
- UONEK 29.7M
- COEP 30.5M
- IPO Year
- UONEK N/A
- COEP N/A
- Fundamental
- Price
- UONEK $0.71
- COEP $9.48
- Analyst Decision
- UONEK
- COEP
- Analyst Count
- UONEK 0
- COEP 0
- Target Price
- UONEK N/A
- COEP N/A
- AVG Volume (30 Days)
- UONEK 37.1K
- COEP 42.3K
- Earning Date
- UONEK 03-27-2025
- COEP 05-09-2025
- Dividend Yield
- UONEK N/A
- COEP N/A
- EPS Growth
- UONEK N/A
- COEP N/A
- EPS
- UONEK N/A
- COEP N/A
- Revenue
- UONEK $449,674,000.00
- COEP N/A
- Revenue This Year
- UONEK N/A
- COEP N/A
- Revenue Next Year
- UONEK N/A
- COEP N/A
- P/E Ratio
- UONEK N/A
- COEP N/A
- Revenue Growth
- UONEK N/A
- COEP N/A
- 52 Week Low
- UONEK $0.60
- COEP $2.31
- 52 Week High
- UONEK $2.07
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- UONEK 48.92
- COEP 45.50
- Support Level
- UONEK $0.65
- COEP $9.01
- Resistance Level
- UONEK $0.75
- COEP $9.75
- Average True Range (ATR)
- UONEK 0.04
- COEP 0.84
- MACD
- UONEK 0.01
- COEP -0.03
- Stochastic Oscillator
- UONEK 69.23
- COEP 46.07
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.